Skip to content
PubMed This is a summary of 55 peer-reviewed journal articles Updated
Neurology · HPCA-Associated Dystonia

HPCA-Associated Dystonia (DYT2): A Patient Guide

At a Glance

HPCA-associated dystonia, formerly called DYT2, is a rare inherited movement disorder caused by two non-working HPCA gene copies. Genetic testing usually confirms it, while care focuses on personalized symptom support and rapid hospital treatment for a sudden, severe worsening.

Receiving a rare diagnosis can feel overwhelming, but understanding the condition is the first step in taking control of your care. HPCA-associated dystonia, formerly known as DYT2, is an exceptionally rare genetic movement disorder that primarily affects how the brain coordinates muscle activity. It is an autosomal recessive condition, meaning it occurs when a person inherits two copies of a non-working HPCA gene—one from each biological parent. This gene is responsible for creating hippocalcin, a protein that helps brain cells in the striatum (the movement control center) manage calcium signals. Current biological models propose that without functioning hippocalcin, these brain cells may become overactive, leading to the involuntary muscle twisting and sustained postures that characterize dystonia [1][2].

The condition typically begins in childhood or adolescence, often starting as focal dystonia in a single limb or the neck. Over time, these symptoms frequently progress to generalized dystonia, where the movements affect most of the body. While the primary issue is motor control, researchers have noted that some individuals also experience occasional non-motor features, such as developmental delays, speech difficulties, or cognitive challenges. Because the physical structure of the brain is usually unaffected, a standard brain MRI will typically appear normal. While an MRI is helpful for ruling out other issues, specialized genetic testing is usually needed to establish a molecular diagnosis [2][3].

Because this condition is so rare, the most critical step in early management is ruling out “look-alike” conditions that have specific, life-changing treatments. Disorders like Wilson disease or Dopa-Responsive Dystonia (DRD) can mimic the symptoms of HPCA variants but require entirely different medical interventions. Once these mimics are ruled out, care transitions to a highly individualized, multidisciplinary approach. There is currently no single “cure” for HPCA-associated dystonia; instead, a team of specialists works together to manage symptoms, prevent complications like joint stiffness, and support quality of life [4][5].

Living with this diagnosis also requires awareness of a rare but serious emergency called status dystonicus, or a “dystonic storm.” This is an escalation of muscle spasms that can evolve over hours or days and may be life-threatening if not treated in a hospital. While the rarity of the condition means local doctors may have never seen it, having a specialized care team—including movement disorder specialists, your primary care physician, and therapists—ensures that unique needs are monitored. By focusing on nutrition, communication, and tailored interventions, families and patients can navigate the complexities of this rare journey with a clear and proactive plan [6][7].

Common questions in this guide

What is HPCA-associated dystonia, and is it the same as DYT2?
HPCA-associated dystonia is an exceptionally rare inherited movement disorder caused by changes in both copies of the HPCA gene. DYT2 is the older name used for this condition in some medical literature.
How is HPCA-associated dystonia diagnosed?
A specialized genetic test is usually needed to identify two disease-causing HPCA variants and confirm the inheritance pattern. A brain MRI is often normal, but it can help doctors rule out other causes of dystonia.
Which treatable conditions should be ruled out first?
Wilson disease and dopa-responsive dystonia can look like HPCA-associated dystonia but have different, potentially beneficial treatments. Clinicians may order specific tests before settling on a long-term management plan.
What care is available if there is no cure?
There is no single cure, so treatment is tailored to the person’s symptoms and goals. A multidisciplinary team can manage movements, help prevent complications such as joint stiffness, and support nutrition, communication, and quality of life.
What should I do if dystonia suddenly becomes much worse?
A rapid, severe increase in spasms over hours or days may be status dystonicus, also called a dystonic storm. This can be life-threatening and needs urgent evaluation and treatment in a hospital.
What does autosomal recessive inheritance mean for my family?
It means a person has two non-working HPCA gene copies, with one inherited from each biological parent. Both biological parents may be tested to clarify how the variants were inherited, and a genetics professional can explain what the results mean for relatives.

Get notified when new evidence is published on Primary dystonia, DYT2 type.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (7)
  1. 1

    Mutations in HPCA cause autosomal-recessive primary isolated dystonia.

    Charlesworth G, Angelova PR, Bartolomé-Robledo F, et al.

    American journal of human genetics 2015; (96(4)):657-65.

    PMID: 25799108
  2. 2

    Childhood-Onset Choreo-Dystonia Due to a Recurrent Novel Homozygous Nonsense HPCA Variant: Case Series and Literature Review.

    Magrinelli F, Bhatia KP, Beiraghi Toosi M, et al.

    Movement disorders clinical practice 2023; (10(1)):101-108 doi:10.1002/mdc3.13529.

    PMID: 36698997
  3. 3

    Specific Cognitive Changes due to Hippocalcin Alterations? A Novel Familial Homozygous Hippocalcin Variant Associated with Inherited Dystonia and Altered Cognition.

    Siegert S, Schmidt WM, Pletschko T, et al.

    Neuropediatrics 2021; (52(5)):377-382 doi:10.1055/s-0040-1722686.

    PMID: 33511595
  4. 4

    Clinical Management of Dystonia in Childhood.

    Luc QN, Querubin J

    Paediatric drugs 2017; (19(5)):447-461 doi:10.1007/s40272-017-0243-3.

    PMID: 28620849
  5. 5

    The genetic landscape of childhood-onset dystonia in a nationwide Turkish cohort: Clinical spectrum, molecular diagnostics, and therapeutic implications.

    Yilmaz S, Serdaroglu E, Simsek E, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2026; (62()):51-60 doi:10.1016/j.ejpn.2026.06.003.

    PMID: 42308683
  6. 6

    Status Dystonicus: An Updated Review on Diagnosis, Pathophysiology, and Management.

    Desai VN, Garg A, Bhattacharya A, et al.

    Annals of Indian Academy of Neurology 2026; (29(4)):501-509 doi:10.4103/aian.aian_1122_25.

    PMID: 42574201
  7. 7

    Emerging Subspecialties: Pediatric Movement Disorders Neurology.

    Kahlon S, Barton CR, Abu Libdeh A, et al.

    Neurology 2024; (102(2)):e208050 doi:10.1212/WNL.0000000000208050.

    PMID: 38165345

This page is for informational purposes only and does not constitute medical advice. A movement-disorder or genetics specialist should interpret your test results and advise you about symptoms, care, and emergencies.